You have 9 free searches left this month | for more free features.

Condition

Androgen Receptor Positive (1)

Estrogen Receptor Negative (1)

HER2/Neu Negative (1)

Mammographic Density (1)

Metastatic Breast Cancer (1)

Metastatic Triple-Negative Breast Carcinoma (1)

Progesterone Receptor Negative (1)

Stage IV Breast Cancer AJCC v6 and v7 (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

phase 3 (1)

Sponsor

City of Hope Medical Center (1)

Havah Therapeutics Pty Ltd (1)

Veru Inc. (1)

Collaborator

GTx (1)

National Cancer Institute (NCI) (1)

Intervention

enobosarm (3)

exemestane (1)

laboratory biomarker analysis (1)

pembrolizumab (1)

Study Documents

Intervention Type

drug (3)

biological (1)

other (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

enobosarm

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Androgen Receptor Positive, Estrogen Receptor Negative, HER2/Neu Negative Trial in United States (drug, other, biological)

Active, not recruiting

Has Results

Androgen Receptor Positive
+5 more

Enobosarm
+2 more

Corona, California
+6 more

Jun 8, 2022

Metastatic Breast Cancer Trial in Worldwide (Enobosarm, Exemestane)

Recruiting

Metastatic Breast Cancer

Enobosarm
Exemestane

Anchorage, Alaska
+58 more

Jan 6, 2023

Mammographic Density Trial in Toorak Gardens (enobosarm)

Completed

Mammographic Density

enobosarm

Toorak Gardens, South Australia, Australia

Wellend Health

Apr 17, 2018